Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Not enough data to support multiple annual COVID boosters, U.S. CDC advisers say

Published 02/24/2023, 03:28 PM
Updated 02/24/2023, 04:51 PM
© Reuters. FILE PHOTO: A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014.   REUTERS/Tami Chappell

By Aditya Samal

(Reuters) - There is not sufficient evidence to recommend more than one COVID-19 booster shot a year for older people and those with weakened immune systems, an expert advisory group to the U.S. Centers for Disease Control and Prevention (CDC) said on Friday.

The COVID-19 working group of the CDC's Advisory Committee For Immunization Practices (ACIP) supported an annual booster campaign, likely in the fall, especially for populations considered at high risk, Dr. Sara Oliver, a CDC official who heads the group, said during a meeting of the agency's outside advisers.

The agency currently recommends older and immunocompromised people receive COVID booster shots more frequently since vaccine effectiveness usually wanes faster for those populations compared to younger people with robust immune systems.

In the spring of 2022, the CDC recommended immunocompromised and people over age 50 receive an additional shot if they had received their first booster at least four months earlier.

The CDC advisers did not vote on new recommendations for how the COVID-19 shots should be administered on Friday.

But ACIP advised showing flexibility in recommendations for those with compromised or weakened immune systems to allow more frequent doses for those most vulnerable to severe COVID.

Both the CDC and the U.S. Food and Drug Administration are working on how to best update COVID vaccines to target circulating variants annually, similar to flu vaccine campaigns.

About 53.3 million people in the United States - around 16% of the U.S. population - have received a COVID-19 booster shot since updated versions of the vaccines were authorized in September.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

That compares with 230 million people, around 70% of the population, that received an initial two-dose series of the COVID vaccines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.